Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688626.SS

SELLREMOVE

Xiangyu Medical Co.,Ltd · Healthcare · China · $1.2B · Avg Vol: $14M/d

20
StockRank
Q
49
V
17
M
44
P/E (TTM)
94.2x
ROE
3.8%
D/E
0.3x
Dividend %
0.4%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
AI CONVICTION THESIS

Xiangyu Medical provides rehabilitation equipment in China, a sector heavily dependent on public hospital procurement budgets. With local government fiscal constraints and centralized procurement pressures, the company faces structural headwinds that outweigh any minor growth signals.

COMPANY DESCRIPTION

Xiangyu Medical Co.,Ltd designs and manufactures a comprehensive range of rehabilitation medical equipment, covering physical therapy, occupational therapy, and hydrotherapy. The company is a market leader in China's rapidly growing rehabilitation sector, serving hospitals, nursing homes, and community health centers. Its competitive moat is built on its extensive product portfolio of over 400 product models, a nationwide sales network, and strong alignment with national healthcare policies promoting rehabilitation services.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue72M110M110M113M16.3%
EPS0.120.210.100.08-13.6%
Shares160M160M160M160M0.0%
Debt3M5M54M85M222.3%
Equity285M309M301M306M2.4%
Op CF28M34M26M28M0.6%
Inv CF-26M-35M-41M-59M—
Fin CF-17M-9M22M28M—
Loading...
PRICE (1M)-22.4%
6.967.578.188.799.40May 8May 29Jun 18
SMA 50SMA 200
Close
$7.11
RSI (14)
34.3
52W High
$13.99
From 52W High
0.5%

SCORE BREAKDOWN

Quality
49
ROIC
3.5%52.3
ROE
3.8%53.0
GP/Assets
14.9%34.9
Op. Margin
14.4%74.1
FCF/Assets
-11.7%25.9
Piotroski
—83.4
Int. Cover
14.1x69.6
D/E Ratio
0.32x42.2
Current Ratio
1.68x29.7
Value
17
P/E (TTM)
94.2x9.8
EV/EBITDA
83.1x3.9
P/FCF
—N/A
P/B
3.6x32.7
P/S
10.1x25.7
Div Yield
0.4%10.9
Momentum
44
52W High %
51%24.6
RS 6M
-12%65.7
SMA 50/200
0.97x54.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
10%53.6

FUNDAMENTALS

Market Cap
$1.2B
P/E (Forward)
—
Gross Margin
62.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688626.SS are excluded.

TickerCompanyMkt CapStockRankSignal
688626.SSXiangyu Medical Co.,Ltd(you)$1.2B20SELL
1609.HKStar Sports Medicine Co., Ltd.$1.4B26SELL
301602.SZShantou Institute of Ultrasonic Instrument Co., Ltd.$1.0B15STRONG SELL
300633.SZSonoScape Medical Corp.$1.3B28SELL
0853.HKMicroPort Scientific Corporation$1.8B22SELL
300869.SZContec Medical Systems Co.,Ltd$681M21SELL
688575.SSShenzhen YHLO Biotech Co., Ltd.$870M26SELL
688085.SSShanghai Sanyou Medical Co., Ltd$755M17STRONG SELL
688656.SSHOB Biotech Group Corp.,Ltd$1.0B6STRONG SELL
301370.SZGKHT Medical Technology Co., Ltd.$629M24SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.0%

Xiangyu Medical Co.,Ltd (688626.SS) — Stock Score Summary

Xiangyu Medical Co.,Ltd (688626.SS) has a MoatMap StockRank of 20/100 based on Quality (49/100), Value (17/100), and Momentum (44/100) factor scores. The current signal is SELL. Xiangyu Medical provides rehabilitation equipment in China, a sector heavily dependent on public hospital procurement budgets. With local government fiscal constraints and centralized procurement pressures, the company faces structural headwinds that outweigh any minor growth signals.

Xiangyu Medical Co.,Ltd designs and manufactures a comprehensive range of rehabilitation medical equipment, covering physical therapy, occupational therapy, and hydrotherapy. The company is a market leader in China's rapidly growing rehabilitation sector, serving hospitals, nursing homes, and community health centers. Its competitive moat is built on its extensive product portfolio of over 400 product models, a nationwide sales network, and strong alignment with national healthcare policies promoting rehabilitation services.

Key Financial Metrics

Price$7.11
Market Cap$1.2B
P/E (TTM)94.23
Price/Book3.63
Return on Equity3.8%
Return on Invested Capital3.5%
Debt/Equity31.93
Gross Margin62.6%
Operating Margin14.4%
Revenue Growth3.8%
Dividend Yield0.4%
Free Cash Flow$-8M

Xiangyu Medical Co.,Ltd operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Xiangyu Medical Co.,Ltd’s (688626.SS) StockRank?
MoatMap’s StockRank for Xiangyu Medical Co.,Ltd (688626.SS) is 20/100, with a Sell signal. It is a composite of Quality (49), Value (17), and Momentum (44) factor ranks across MoatMap’s 20,000+ stock universe.
Does Xiangyu Medical Co.,Ltd have an economic moat?
Xiangyu Medical Co.,Ltd (688626.SS) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Xiangyu Medical Co.,Ltd a buy, hold, or sell?
MoatMap’s current signal for Xiangyu Medical Co.,Ltd (688626.SS) is Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Xiangyu Medical Co.,Ltd in?
Xiangyu Medical Co.,Ltd (688626.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).
Browse all ranked stocks688626.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock